Zhonghua Gan Zang Bing Za Zhi. 2022 Aug 20;30(8):832-845. doi: 10.3760/cma.j.cn501113-20220616-00330.
In order to effectively prevent recurrence, improve the prognosis and increase the survival rate of primary liver cancer (PLC) patients with radical cure, the Chinese Society of Hepatology, Chinese Medical Association organized the relevant experts to develop the consensus on tertiary prevention of PLC (2022 version), which based on domestic and international research progress on the risk factors, pathological and clinical features, prevention of recurrence of PLC, combined with the present actual situation in China. The purpose is to provide a current basis for the prevention, surveillance, early detection and diagnosis, the effective measures of PLC recurrence.
为有效预防原发性肝癌（PLC）根治性治疗患者的复发，改善预后并提高生存率，中华医学会肝病学分会组织相关专家制定了《原发性肝癌三级预防共识（2022年版）》，该共识基于国内外关于PLC危险因素、病理及临床特征、复发预防的研究进展，并结合我国目前的实际情况。目的是为PLC复发的预防、监测、早期发现与诊断及有效措施提供当前依据。
